524506 — Coral Laboratories Balance Sheet
0.000.00%
- IN₹1.77bn
- IN₹789.78m
- IN₹859.00m
Annual balance sheet for Coral Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 243 | 300 | 278 | 309 | 307 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 524 | 461 | 498 | 533 | 530 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,308 | 1,235 | 1,539 | 1,765 | 1,770 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 245 | 243 | 233 | 242 | 432 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,899 | 1,743 | 2,057 | 2,295 | 2,407 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 255 | 119 | 249 | 250 | 273 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 338 | 195 | 282 | 283 | 315 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,561 | 1,548 | 1,775 | 2,012 | 2,091 |
| Total Liabilities & Shareholders' Equity | 1,899 | 1,743 | 2,057 | 2,295 | 2,407 |
| Total Common Shares Outstanding |